(Date:9/5/2008)...G, Pa., Sept. 5 /PRNewswire-USNewswire/ -- Childre...r access to comprehensive,services to protect thei...n,in grants that were announced today by the Depar...vices for children and families, the department,be...ren,s Services Planning,initiative, ICSP, in 2004....
(Date:9/5/2008)..., Md., Sept. 5 /PRNewswire-USNewswire/ -- The Heal...day announced $39 million in grants to,increase an...centers., "These grants continue President Bush,s...whose services now reach more economically,vulnera...r before," HRSA,Administrator Elizabeth M. Duke sa...
(Date:9/5/2008)...ontrolled, but you need to know what triggers them...thDay News) -- If you are one of the 36 million Am...is nowhere in the United States that is free from ... shows. , Allergies don,t only happen in the sp...ell. In the fall, the most challenging cities to l...
(Date:9/5/2008)...N, Sept. 5 /PRNewswire-USNewswire/ -- Speaker Nanc...upport of the aims of the "Stand,Up to Cancer" tel...re is not a person in our country who has not seen...s 565,000 Americans annually, and each,year there ... must work,together to make eradicating the scourg...
Breaking Medicine News(10 mins):Health News:Pennsylvania Counties Receive Grants to Improve Services for Children 2Health News:HRSA Announces $39 Million in Grants to Expand, Improve Health Center Services 2Health News:No Place Safe From Allergies 2...ing in a French school, hospital, metro station, o...e first time to a stiff fine as the first stage of... places went into effect. The ban covers schools,...' offices, sports halls, train stations, airports,...
...ng an outbreak of bird flu in a poultry farm in Su... Reports of an ‘unexplained’ illness// had many ex...ion has been received from The Department of Envir... bird-flu outbreak. This is the second attack of b...
...lipid plays a crucial role in shaping a hollow sph...ave found. It seems to help in organizing// tissue...tions. They found that in the first few days of l...p to form the primitive ectoderm from which embryo...
...lege of Medicine finds that naltrexone may be bene...of this drug is often used to bring// relief to vi...ase is a chronic inflammatory disorder of the inte...0 Americans. The study results were released onlin...
Other Medicine News:Health News:Ceramide Directs Stem Cells in Embryo 2(Date:9/4/2008)...LBOURNE, Australia, Sept. 4 /- Cytopi...mmencing enrolment for its Phase Ib/II,study of CY...cancer agent,in patients with an aggressive form ...GBM)., The GBM clinical trial is the first Phase ...indications for the company and the second in its,...
(Date:9/4/2008)...actice Bulletin for Obstetrician-Gynecologists Sta...ce Change-Minimally Invasive Interventional,Radiol...With Uterine,Fibroids, FAIRFAX, Va., Sept. 4 /PRN...al Radiology, a national organization of nearly 4,...onals dedicated to improving health,care through m...
(Date:9/4/2008)...mg cohort demonstrates potent antiviral activity a...profile -, CAMBRIDGE, Mass., Sept. 4 /PRNewswire-...: IDIX ), a biopharmaceutical company engaged,in ...atment of human viral,and other infectious disease...-of-concept study evaluating IDX899, a non-nucleos...
(Date:9/3/2008)...NJING, China, Sept. 3 /- Si...g manufacturer and supplier of,branded generic pha...-cancer biotech product Endu (also known as Endost...u Phase IV clinical study., At the request of the...,to further validate the safety and therapeutic ef...
Breaking Medicine Technology:Cytopia Commences Second Phase II Study in Brain Cancer 2Cytopia Commences Second Phase II Study in Brain Cancer 3Society of Interventional Radiology Applauds Report's Uterine Fibroid Embolization Recommendations 2Society of Interventional Radiology Applauds Report's Uterine Fibroid Embolization Recommendations 3Idenix Pharmaceuticals Announces Completion of Proof-of-Concept Study for IDX899 in Treatment-Naive HIV-Infected Patients 2Idenix Pharmaceuticals Announces Completion of Proof-of-Concept Study for IDX899 in Treatment-Naive HIV-Infected Patients 3Idenix Pharmaceuticals Announces Completion of Proof-of-Concept Study for IDX899 in Treatment-Naive HIV-Infected Patients 4Simcere Pharmaceutical Group Announces Interim Results of Endu Phase IV Clinical Study 2Simcere Pharmaceutical Group Announces Interim Results of Endu Phase IV Clinical Study 3First study examines newly licensed RN work attitudes and intentions 234 1First study examines newly licensed RN work attitudes and intentions 234 2First study examines newly licensed RN work attitudes and intentions 234 3RA Drugs Linked to Slight Skin Cancer Risk 232 1RA Drugs Linked to Slight Skin Cancer Risk 232 2Who will recover spontaneously from hepatitis C virus infection 175 1Who will recover spontaneously from hepatitis C virus infection 175 2Modigene to Present at the Roth 2007 New York Investor Conference 240 1Modigene to Present at the Roth 2007 New York Investor Conference 240 2Modigene to Present at the Roth 2007 New York Investor Conference 240 3...ELD, Ill., March 29, 2007 /PRNewswire-FirstCall/ -...Phase I/II data for its,adjuvant-free investigatio...nitiate a Phase III clinical trial of the candidat..., The Phase I/II study indicated that Baxter,s H5N...oses, and induces substantial,levels of cross immu...
...ascular Ultrasound Demonstrates Utility in Evaluat...normous Potential for HDL,Therapy , ,PLEASANTON, C...rk),-- Lipid Sciences, Inc. (NASDAQ: LIPD) Dr. H. ...pid Sciences, Inc., concluded from,the wide range ...,Cardiology (ACC) Meeting in New Orleans that the ...
Other Medicine Technology:Baxter Announces Final Phase I/II Data and Initiation of Phase III,Clinical Trial for Candidate Pandemic H5N1 Influenza Vaccine 2Baxter Announces Final Phase I/II Data and Initiation of Phase III,Clinical Trial for Candidate Pandemic H5N1 Influenza Vaccine 3Baxter Announces Final Phase I/II Data and Initiation of Phase III,Clinical Trial for Candidate Pandemic H5N1 Influenza Vaccine 4Baxter Announces Final Phase I/II Data and Initiation of Phase III,Clinical Trial for Candidate Pandemic H5N1 Influenza Vaccine 5Presentations at American College of Cardiology Meeting Highlight,New Opportunities for HDL Therapy 2Presentations at American College of Cardiology Meeting Highlight,New Opportunities for HDL Therapy 3Presentations at American College of Cardiology Meeting Highlight,New Opportunities for HDL Therapy 4Presentations at American College of Cardiology Meeting Highlight,New Opportunities for HDL Therapy 5The Clinac 2300 C/D family of accelerators are reliable, easy-to-use, flexible and cost-effective systems.
The Clinac 6EX accelerator is a cost-effective choice. Configured for the latest treatment techniques, the Clinac 6EX has the tightest mechanical and dosimetric specifications for any single-energy m
Based on the clinically proven ACS MULTI-LINK Stent, ULTRA is a coronary stent system specifically designed for use in larger vessels. This innovative system utilizes a unique stent pattern to give y
The MULTI-LINK RX PENTA Coronary Stent Systems with new ACCESS-LINK Stent Design are indicated for improving coronary luminal diameter.
Medicine Products: